Literature DB >> 21691887

The use of the Boussignac CPAP device during cardiogenic pulmonary edema (CPE): why add air to the oxygen gas source?

François Templier, Maidei Gugu Kabayadondo, Frédéric Thys.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21691887     DOI： 10.1007/s00134-011-2278-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  'Boussignac' continuous positive airway pressure system: practical use in a prehospital medical care unit.

Authors:  François Templier; François Dolveck; Michel Baer; Marcel Chauvin; Dominique Fletcher
Journal:  Eur J Emerg Med       Date:  2003-06       Impact factor: 2.799

2.  Non-invasive pressure support ventilation and CPAP in cardiogenic pulmonary edema: a multicenter randomized study in the emergency department.

Authors:  Semir Nouira; Riadh Boukef; Wahid Bouida; Wieme Kerkeni; Kaouther Beltaief; Hamdi Boubaker; Latifa Boudhib; Mohamed Habib Grissa; Mohamed Naceur Trimech; Hamadi Boussarsar; Mehdi Methamem; Soudani Marghli; Mondher Ltaief
Journal:  Intensive Care Med       Date:  2010-12-07       Impact factor: 17.440

Review 3.  The use of noninvasive ventilation in emergency department patients with acute cardiogenic pulmonary edema: a systematic review.

Authors:  Sean P Collins; Lisa M Mielniczuk; Heather A Whittingham; Mark E Boseley; David R Schramm; Alan B Storrow
Journal:  Ann Emerg Med       Date:  2006-04-25       Impact factor: 5.721

4.  [Laboratory testing measurement of FIO2 delivered by Boussignac CPAP system with an input of 100% oxygen].

Authors:  F Templier; F Dolveck; M Baer; M Chauvin; D Fletcher
Journal:  Ann Fr Anesth Reanim       Date:  2003-02

5.  Continuous positive airway pressure versus bilevel noninvasive ventilation in acute cardiogenic pulmonary edema: a randomized multicenter trial.

Authors:  Fabienne Moritz; Benoit Brousse; Bruno Gellée; Abdesslam Chajara; Erwan L'Her; Marie-France Hellot; Jacques Bénichou
Journal:  Ann Emerg Med       Date:  2007-08-30       Impact factor: 5.721
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.